154 related articles for article (PubMed ID: 27959383)
1. Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway.
Ling S; Song L; Fan N; Feng T; Liu L; Yang X; Wang M; Li Y; Tian Y; Zhao F; Liu Y; Huang Q; Hou Z; Xu F; Shi L; Li Y
Int J Oncol; 2017 Jan; 50(1):297-309. PubMed ID: 27959383
[TBL] [Abstract][Full Text] [Related]
2. Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells.
Zhang Y; Zhang B; Zhang A; Zhao Y; Zhao J; Liu J; Gao J; Fang D; Rao Z
Clinics (Sao Paulo); 2012 Sep; 67(9):1093-9. PubMed ID: 23018309
[TBL] [Abstract][Full Text] [Related]
3. Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells.
Okagawa Y; Takada K; Arihara Y; Kikuchi S; Osuga T; Nakamura H; Kamihara Y; Hayasaka N; Usami M; Murase K; Miyanishi K; Kobune M; Kato J
PLoS One; 2016; 11(12):e0168355. PubMed ID: 27977808
[TBL] [Abstract][Full Text] [Related]
4. mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma.
Scheller T; Hellerbrand C; Moser C; Schmidt K; Kroemer A; Brunner SM; Schlitt HJ; Geissler EK; Lang SA
Br J Cancer; 2015 Mar; 112(5):841-50. PubMed ID: 25688743
[TBL] [Abstract][Full Text] [Related]
5. NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis.
Tan XL; Wang Z; Liao S; Yi M; Tao D; Zhang X; Leng X; Shi J; Xie S; Yang Y; Liu YQ
Cancer Sci; 2024 Feb; 115(2):465-476. PubMed ID: 37991109
[TBL] [Abstract][Full Text] [Related]
6. Targeted degradation of NDUFS1 by agrimol B promotes mitochondrial ROS accumulation and cytotoxic autophagy arrest in hepatocellular carcinoma.
Dong L; Luo L; Wang Z; Lian S; Wang M; Wu X; Fan J; Zeng Y; Li S; Lv S; Yang Y; Chen R; Shen E; Yang W; Li C; Wang K
Free Radic Biol Med; 2024 Aug; 220():111-124. PubMed ID: 38697493
[TBL] [Abstract][Full Text] [Related]
7. LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.
Tang F; Gao R; Jeevan-Raj B; Wyss CB; Kalathur RKR; Piscuoglio S; Ng CKY; Hindupur SK; Nuciforo S; Dazert E; Bock T; Song S; Buechel D; Morini MF; Hergovich A; Matthias P; Lim DS; Terracciano LM; Heim MH; Hall MN; Christofori G
Nat Commun; 2019 Dec; 10(1):5755. PubMed ID: 31848340
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma.
Franco-Juárez EX; González-Villasana V; Camacho-Moll ME; Rendón-Garlant L; Ramírez-Flores PN; Silva-Ramírez B; Peñuelas-Urquides K; Cabello-Ruiz ED; Castorena-Torres F; Bermúdez de León M
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339037
[TBL] [Abstract][Full Text] [Related]
9. Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition.
Wu R; Murali R; Kabe Y; French SW; Chiang YM; Liu S; Sher L; Wang CC; Louie S; Tsukamoto H
Hepatology; 2018 Nov; 68(5):1726-1740. PubMed ID: 29729190
[TBL] [Abstract][Full Text] [Related]
10. Role of metformin in the diagnosis, prevention, and treatment of hepatocellular carcinoma.
Xiong S; Liu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):364-373. PubMed ID: 35545330
[TBL] [Abstract][Full Text] [Related]
11. Antitumor Activity of Metformin Combined with Locoregional Therapy for Liver Cancer: Evidence and Future Directions.
Choksi EJ; Elsayed M; Kokabi N
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760509
[TBL] [Abstract][Full Text] [Related]
12. Metformin: Restraining Nucleocytoplasmic Shuttling to Fight Cancer and Aging.
Castillo-Quan JI; Blackwell TK
Cell; 2016 Dec; 167(7):1670-1671. PubMed ID: 27984715
[TBL] [Abstract][Full Text] [Related]
13. An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer.
Wu L; Zhou B; Oshiro-Rapley N; Li M; Paulo JA; Webster CM; Mou F; Kacergis MC; Talkowski ME; Carr CE; Gygi SP; Zheng B; Soukas AA
Cell; 2016 Dec; 167(7):1705-1718.e13. PubMed ID: 27984722
[TBL] [Abstract][Full Text] [Related]
14. MATE2 Expression Is Associated with Cancer Cell Response to Metformin.
Chowdhury S; Yung E; Pintilie M; Muaddi H; Chaib S; Yeung M; Fusciello M; Sykes J; Pitcher B; Hagenkort A; McKee T; Vellanki R; Chen E; Bristow RG; Wouters BG; Koritzinsky M
PLoS One; 2016; 11(12):e0165214. PubMed ID: 27959931
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer.
Mayer MJ; Klotz LH; Venkateswaran V
J Urol; 2017 Apr; 197(4):1068-1075. PubMed ID: 27984108
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?
Shah RR
Drug Saf; 2017 Mar; 40(3):211-228. PubMed ID: 27981444
[TBL] [Abstract][Full Text] [Related]
17. Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines.
Hirasawa K; Moriya S; Miyahara K; Kazama H; Hirota A; Takemura J; Abe A; Inazu M; Hiramoto M; Tsukahara K; Miyazawa K
PLoS One; 2016; 11(12):e0164529. PubMed ID: 27977675
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of platinum plus gemcitabine (PG) chemotherapy with or without molecular targeted agent (MTA) in first-line treatment of non-small cell lung cancer (NSCLC).
Yang J; He J; Yu M; Li T; Luo L; Liu P
Medicine (Baltimore); 2016 Dec; 95(50):e5599. PubMed ID: 27977596
[TBL] [Abstract][Full Text] [Related]
19. Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy.
Li F; Zhang N; Wu Q; Yuan Y; Yang Z; Zhou M; Zhu J; Tang Q
Int J Mol Med; 2017 Jan; 39(1):199-207. PubMed ID: 27959392
[TBL] [Abstract][Full Text] [Related]
20. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
